AG000KLF

123441-03-2 | 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate

AG000KLF

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	123441-03-2
Catalog Number	AG000KLF(AGN-PC-0PHI78)
Chemical Name	3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
EC Number	602-936-0
IUPAC Name	[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
InChI	InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1
InChI Key	XSVMFMHYUFZWBK-NSHDSACASA-N
MDL Number	MFCD00871496
Molecular Formula	C14H22N2O2
Molecular Weight	250.3367
SMILES	O=C(OC1=CC=CC([C@@H](N(C)C)C)=C1)N(CC)C
UNII	PKI06M3IW0
Synonyms	(S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate, 713, ENA, 713, SDZ ENA, ENA 713, ENA 713, SDZ, ENA-713, ENA713, Exelon, Hydrogen Tartrate, Rivastigmine, rivastigmine, Rivastigmine Hydrogen Tartrate, RivastigmineTartrate, SDZ ENA 713, Tartrate, Rivastigmine Hydrogen, rivastigmine, 123441-03-2, Exelon, ENA 713 free base, ENA-713, Exelon Patch, UNII-PKI06M3IW0, SDZ-ENA-713, (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate, CHEMBL636, SDZ 212-713, SDZ-212-713, PKI06M3IW0, (S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate, CHEBI:8874, m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate, 3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate, Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, W-200966, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate, Nimvastid, 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate, S-Rivastigmine, [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate, Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, Rivastigmine Teva, 415973-05-6, SR-05000001475, Rivastigmine [USAN:INN], Rivastigmine Transdermal System, Prometax (TN), AK161672, Rivastigmine [USAN:INN:BAN:JAN], Rivastigmine.tartrate, SCHEMBL2764, MLS003876822, BIDD:GT0316, AC1L2U92, GTPL6602, Rivastigmine (JAN/USAN/INN), ZINC4413, (S)-1-(3-((ethyl(methyl)carbamoyl)oxy)phenyl)-N,N-dimethylethanamine, DTXSID7023564, BDBM10620, BDBM11682, XSVMFMHYUFZWBK-NSHDSACASA-N, HMS2089H18, HMS3715P15, EBD46209, ABP001082, MFCD00871496, AKOS015896334, AC-8250, AN-1074, API0008913, CCG-221197, CS-0946, DB00989, RL06150, KS-00000H18, NCGC00167531-03, AJ-08211, BC225687, CC-34273, HY-17368, SMR002203623, AB1004572, LS-172571, FT-0651952, S4687, ST24049123, Y9059, (R)-Rivastigmine (Rivastigmine EP Impurity D), C11766, D03822, F10108, W-5183, AB01275472-01, AB01275472_02, AB01275472_03, 101R548, C-23825, I06-2037, SR-05000001475-1, SR-05000001475-2, (S)-3-[1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate, [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate, [3-[(1S)-1-dimethylaminoethyl]phenyl] N-ethyl-N-methylcarbamate, 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate, 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl N-methyl carbamate, Ethyl-methyl-carbamic acid 3-(1-dimethylamino-ethyl)-phenyl ester, Ethyl-methyl-carbamic acid 3-((R)-1-dimethylamino-ethyl)-phenyl ester, Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester, Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, 2,3-dihydroxybutanedioic acid; 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate, 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate; Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, Exelon; Rivastigmine hydrogen tartrate; 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate; Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester; 3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate; ethylmethyl-Carbami, Prometax, Rivastigmine tartrate, rivastigmine hexal, (S)-Rivastigmine, RivastigmineTartrate, Exelon (TN), Rivastigmine Hydrogen Tartrate, SDZ ENA 713, ENA 713, D0WY5Q, SDZ-ENA 713, 713, SDZ ENA, C14H22N2O2, ENA 713, SDZ, ENA713, Hydrogen Tartrate, Rivastigmine, Tartrate, Rivastigmine Hydrogen, Rivastigmine (transdermal patch), (R)-Rivastigmine-d6 Tartrate Salt, 713, ENA, CID77991, C14-H22-N2-O2, ACN-034450, Rivastigmine tartrate, 99% - 1G 1g, NCGC00167531-01, 2175B, A3768, C072506, 3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate, D000068836, (s)-n-ethyl-3-[(1-dimethylamino)ethyl]-n-methylphenylcarbamate, (S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate, 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate, 129101-54-8, Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1), Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester,

Complexity	269
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	250.168g/mol
Formal Charge	0
Heavy Atom Count	18
Hydrogen Bond Acceptor Count	3
Hydrogen Bond Donor Count	0
Isotope Atom Count	0
Molecular Weight	250.342g/mol
Monoisotopic Mass	250.168g/mol
Rotatable Bond Count	5
Topological Polar Surface Area	32.8A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	2.3

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number